Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group
作者:
发布时间
2023-06-27
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文